Tirzepatide (GLP-2)

Tirzepatide is a dual-receptor agonist (GLP-1 and GIP) studied intensively in the metabolic category for its combined effects on appetite and glucose regulation. Research has focused on how activating both incretin pathways may influence blood-sugar control and body-weight management. This 5 mg vial is the entry size in our Tirzepatide range, a popular starting point for a study protocol. It is supplied as a lyophilized powder for reconstitution with bacteriostatic water. Provided strictly for laboratory research use only, not for human consumption.